학술논문
Phase II study SECOMBIT (sequential combo immuno and target therapy study): A subgroup analysis with a longer follow-up.
Document Type
ConferencePaper
Author
Source
JOURNAL OF CLINICAL ONCOLOGY. 40(16)
Subject
Language
English
English
English
ISSN
0732-183X